|
|
Volumn 276, Issue 7, 1996, Pages 565-566
|
|
Why sepsis trials fail
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CENTOXIN;
GINKGOLIDE B;
INTERLEUKIN 1;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 6;
METHYLPREDNISOLONE;
MONOCLONAL ANTIBODY;
PROSTAGLANDIN E2;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
CLINICAL TRIAL;
CLONAL ANERGY;
DRUG EFFICACY;
HOMEOSTASIS;
HUMAN;
IMMUNE DEFICIENCY;
INFLAMMATION;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
SEPSIS;
|
|
EID: 0029784526
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.276.7.565 Document Type: Note |
|
Times cited : (202)
|
|
References (0)
|
